Polaris Venture Partners Founders' Fund V, L.P., 10% Owner at T2 Biosystems, Inc. (TTOO), sold 29,998 shares at $18.15 ($546K) on 2015-06-23, disclosed to the SEC on 2015-06-24.
Scheduled sale ($546k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.22 | 99 | $2K | 0.3% |
| 2 | $18.22 | 144 | $3K | 0.5% |
| 3 | $18.22 | 282 | $5K | 0.9% |
| 4 | $18.22 | 14,474 | $264K | 48.3% |
| 5 | $18.15 | 99 | $2K | 0.3% |
| 6 | $18.15 | 144 |
| $3K |
| 0.5% |
| 7 | $18.15 | 282 | $5K | 0.9% |
| 8 | $18.15 | 14,474 | $263K | 48.2% |
| Total | $18.18 avg | 29,998 | $546K | 100% |
| Filing → |
| TTOO | SELL | 2015-07-07 | $716K | — | Filing → |
| OCUL | SELL | 2015-02-04 | $14.8M | — | Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |